SESSION 4: Connected Inhalers:
From Digital Dilemma to Design Reality
Tuesday • May 12, 2026 • 8:30–9:30 AM • Trailblazer’s Ballroom
Moderator: John N. Pritchard, Ph.D.
SESSION 5: Simulation to Submission:
In Silico Strategies for Deposition and Bioequivalence
Tuesday • May 12, 2026 • 10:00–12:00 Noon • Trailblazer’s Ballroom
Moderator: Jan de Backer, Ph.D.
The Digital Dilemma: The Continued Case for Connected Inhalers
Mark Milton-Edwards
Digital Medical Innovation
Digital Medical Innovation
Design for the Future: Navigating the Pathway to Successful Complex Electromechanical Devices
Andreas Meliniotis
Phillips Medisize
Phillips Medisize
Machine Learning (ML) and Artificial Intelligence (AI) in Generic Drug Development of Orally Inhaled Drug Products [Invited]
Steven Chopski
U.S. Food & Drug Administration
U.S. Food & Drug Administration
Accelerating and De‑Risking Inhaled Drug Development with In Silico Tools
Victoria Legh-Land
Microsol Science
Microsol Science
In Silico Modeling To Identify Alternatives To Charcoal Block Pharmacokinetics Bioequivalence Studies [Invited]
Ross Walenga
U.S. Food & Drug Administration
U.S. Food & Drug Administration
Discover More
Advancing Dissolution Testing for Inhaled Drug Products
Paul Martin and Jamie Clayton
Copley Scientific
Copley Scientific
Patient-centric Product Development: Maximizing the Chances of Success in the Clinic and Beyond
Nicola Wilkie and Daniel Lock
Phillips Medisize
Phillips Medisize
Enhancing In Vitro Tools for Reformulating pMDIs with Low-GWP Propellants: Realistic Regional Deposition Models
Improvement in Inhalation Technique During a Pharmacy-Led Connected Inhaler Service Evaluation in Adults with Asthma or Chronic Obstructive Pulmonary Disease
Marco Franza
Amcor
Amcor
Using Rapid Deposition Analysis and Realistic Aerodynamic Particle Size Distribution Variability to Support In Silico Bioequivalence Assessment
Hosein Sadafi and Jan De Backer
FLUIDDA
FLUIDDA
In Silico Evaluation of Nasal Spray Plume Angle and Ovality: Effect on Regional Nasal Deposition
Navid Monshi Tousi and Jan De Backer
FLUIDDA
FLUIDDA
Leachables Toxicological Risk Assessment: Read-Across Case Study of Permissible Daily Exposure Limit Derivation for Butyl Oligomer (C21H40)
Isaac Mohar
Gradient
Gradient
Morphological Characterization of Dry Powder Inhaler Formulations: A Reaction to the US Food and Drug Administration Guidelines
Vaishnavi Kapileshwari and Mridul Majumder
M2M Pharmaceuticals
M2M Pharmaceuticals
Predicting Nasal Deposition from Minimal In Vitro Data with Machine Learning
Ben Miles and Lucas Silva
Nanopharm
Nanopharm
Development of a Connectivity Module for an Open-Inhale-Close Device That is Both Patient-Centric and Non-Intrusive to Dry Powder Delivery
Murat Ali
Phillips Medisize
Phillips Medisize
Predicting Pulmonary Drug Deposition Using Real-Time Connected Inhalation Data
Carolina Dantas and Ulf Krueger
PULMOTREE
PULMOTREE
Particle Level Assessment of Size and Composition as a Function of Aerosol Particle Size Using Optical Photothermal Infrared Microscopy: Comparison of Fluticasone/Salmeterol/Lactose in Advair Diskus and Wixela Inhub
Teri Ross
The University of Alabama at Birmingham
The University of Alabama at Birmingham
Can a Mixing Inlet Interposed Between a Pressurized Metered Dose Inhaler-Spacer Combination and Cascade Impactor Enable Effective Performance Testing at Widely Different Inhalation Flow Rates?
Mark Nagel
Trudell Medical International
Trudell Medical International
Comparative Analysis of Phospholipid Porous Particle Size Distribution in Orally Inhaled Drug Products: In Vitro and In Silico Approaches
Yang Yang and Susan Boc
U.S. Food & Drug Administration
U.S. Food & Drug Administration
Rapid Stability Modeling as a Predictor for Long-Term Standard Stability Testing of Dry Powder Inhalers
Anna Catton
University of Bristol
University of Bristol
Use of a Modified Next Generation Impactor and Franz Cell for Characterization of the In Vitro Dissolution Performances of Innovator and Generic Dry Powder Inhalers
Zhengqi Xu and Dipesh Khanal
University of Sydney
University of Sydney
Combination of a Newly Developed Modified Next Generation Impactor and Franz Cell Method for In Vitro Dissolution Characterization of Inhalation Powders: Development and Validation
Zhengqi Xu and Dipesh Khanal
University of Sydney
University of Sydney
Development and Validation of a Customizable Neonatal Breathing Simulator for Aerosol Delivery Evaluation Using a Laryngeal Mask Airway Aerosol Delivery System
Laura Vargas
Virginia Commonwealth University
Virginia Commonwealth University
Inhaler Usage Recognition Using Transformer-Based Acoustic Modeling
Ziyi Fan and Yuqing Ye
Western University
Western University
CONFERENCE ORGANIZERS
CONFERENCE SUPPORTERS
EXHIBITORS
